Aminopeptidase N (APN) is a member of the highly conserved M1 family of metalloproteases,
and is considered to be a valuable target for the treatment of a variety of diseases,
e.g., cancer, malaria, and coccidiosis. In this study, we identified an APN gene
(TgAPN2) in the Toxoplasma gondii genome, and
performed a biochemical characterization of the recombinant TgAPN2
(rTgAPN2) protein. Active rTgAPN2 was first produced
and purified in Escherichia coli. The catalytic activity of the enzyme
was verified using a specific fluorescent substrate, H-Ala-MCA; the
rTgAPN2 was relatively active in the absence of added metal ions. The
addition of some metal ions, especially Zn2+, inhibited the activity of the
recombinant enzyme. The activity of rTgAPN2 was reduced in the presence
of the EDTA chelator in the absence of added metal ions. The optimum pH for enzyme
activity was 8.0; the enzyme was active in the 3–10 pH range. The substrate preference of
rTgAPN2 was evaluated. The enzyme showed a preference for substrates
containing N-terminal Ala and Arg residues. Finally, bestatin and amastatin were shown to
inhibit the activity of the enzyme. In conclusion, rTgAPN2 shared general
characteristics with the M1 family of aminopeptidases but also had some unique
characteristics. This provides a basis for the function of aminopeptidases and the study
of drug targets.